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The maternal-fetal unit contains three distinct haplotypes at each locus: the maternally derived fetal haplotype (MDFH) that is
shared by the mother and fetus, the paternally derived fetal haplotype (PDFH), and the non-inherited maternal haplotype
(NIMH). The evolutionary forces acting on these haplotypes are distinct. The NIMH is absent from the oﬀspring and could beneﬁt
from early abortion if this enhances the probability of the mother conceiving again and producing an oﬀspring that inherits the
NIMH. This raises the possibility that some forms of recurrent spontaneous abortion may be caused by non-inherited haplotypes.
Such ‘selﬁsh’ behaviour would be opposed by other components of the maternal genome. Natural selection acting on genes
expressed in fetuses (or their placentae) favours greater maternal investment in the fetus than does natural selection acting on genes
expressed in mothers. Furthermore, in the presence of genomic imprinting, the PDFH favours greater levels of investment in the
fetus than does the MDFH. These conﬂicts are illustrated using the example of maternal-fetal conﬂicts over the supply of calcium.
Inactivation of the paternal copy of GNAS in proximal renal tubule is interpreted as a measure to maintain fetal bone mineralization
in times of calcium stress at the expense of the maternal skeleton.  2004 IFPA and Elsevier Ltd. All rights reserved.
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GENETIC FACTIONS IN THE MATERNAL-FETAL
UNIT
Pregnancy is a joint venture involving three sets of genes.
These are genes shared by the mother and fetus (inherited
maternal haplotypes); genes present in the mother but not in
the fetus (non-inherited maternal haplotypes); and genes
present in the fetus but not in the mother (paternally derived
fetal haplotypes). Each set has distinct interests in the outcome
of a pregnancy because of a fundamental evolutionary trade-oﬀ
that exists in the provision of maternal care: extra resources or
eﬀort put into enhancing the survival of any particular oﬀ-
spring is associated with an opportunity cost of less resources
or eﬀort available for other maternal activities. In evolutionary
terms, the opportunity cost of extra care for a particular
oﬀspring has translated into a cost to a mothers’ expected
ﬁtness from other oﬀspring. The existence of this trade-oﬀ
does not require the action of obscure processes. In fact, its
expressions may be rather prosaic. When a human mother
holds a baby, she is less able to grab a toddler who runs across
a road. When a squirrel mother depletes her fat reserves during
lactation, she is more likely to succumb to disease during the
coming winter. Nor does the existence of an evolutionary
trade-oﬀ require that everytime a mother does something to
enhance the ﬁtness of one oﬀspring, another one suﬀers. All
that is required is that this relation has existed on average.
Evolutionary conﬂicts arise during pregnancy because the
reallocation of maternal investment from the current oﬀspring
to other oﬀspring has had diﬀerent ﬁtness consequences for the
three sets of genes in the maternal-fetal unit. How then does
natural selection weigh beneﬁts to one of a mother’s oﬀspring
against costs to her other oﬀspring? I will ﬁrst consider genes
expressed in mothers and then consider genes expressed in
oﬀspring (genes on inherited maternal haplotypes can belong
to either category).
Genes expressed in mothers
A critical factor in determining the selective forces acting on an
allele expressed in mothers is whether or not the allele’s eﬀects
on oﬀspring depend on whether the oﬀspring also possesses a
copy of the allele. If an allele has diﬀerent eﬀects when an
oﬀspring has and has not inherited a copy of the allele, then the
allele can be ﬁguratively said to ‘recognize’ itself in oﬀspring or
to have ‘information’ about its own pattern of inheritance.
Haig [1,2] has discussed simple ways in which genes in
mothers could acquire such information. These mechanisms
involve epistatic interactions between closely linked loci, where
one of the loci is expressed in mothers and the other is
expressed in oﬀspring. By analogy to systems of meiotic drive,
I will refer to these loci as the Distorter locus (expressed in
mothers) and the Responder locus (expressed in oﬀspring).
Epistasis ensures that the eﬀects of an allele at the Distorter
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locus. Therefore, if Responder and Distorter loci are closely
linked and a mother is heterozygous at both loci, then the
eﬀects of an allele at the Distorter locus will diﬀer depending on
whether or not the oﬀspring inherits the allele. Natural
selection will favour two-locus haplotypes that beneﬁt oﬀ-
spring that inherit the haplotype, even if this is at the expense
of siblings that do not. Haig [1,3] used the term ‘gestational
drive’ to refer to such systems in which maternal care is
preferentially directed to oﬀspring who inherit one of the
alleles at a heterozygous locus.
Non-inherited maternal haplotypes (NIMHs) gain no direct
beneﬁt from the survival, health and eventual reproduction of
an embryo in which they are absent. Worse than that, NIMHs
have an interest in the embryo’s early demise because this frees
maternal energies for the care of existing oﬀspring or speeds
the conception of future oﬀspring that may inherit the NIMH
of the current pregnancy. The potential selective advantage to
a gene of eliminating embryos that do not inherit its copies is
so great that I would be surprised if systems of spiteful
abortion have not evolved. However, I know of no unambigu-
ous examples in mammals, and raise the possibility here as
something to keep in mind when a common genetic variant
appears to be associated with inexplicably high reproductive
costs. Recurrent spontaneous abortion would be one place to
look for such systems. In such cases, the genetic culprit may
have been interpreted as ‘protective’ because the haplotype
that is responsible for recurrent abortion is present in the
surviving oﬀspring of aﬀected mothers, but not the aborted
oﬀspring. Geneticists should be aware of the danger of blaming
the victim. (Pregnancy losses so early that they fail to be
detected provide an even stronger selective advantage, but are
unlikely to come to clinical attention).
If non-inherited alleles at every heterozygous locus in a
mother’s genome were actively conspiring against each and
every embryo, it is hard to see how a successful pregnancy
would ever be possible. Embryos are probably saved by a lack
of reliable information available to genes expressed in their
mothers (i.e., by the absence of the necessary forms of
nepotistic epistasis). In this view, most maternal genes lack
information about whether they are inherited by an oﬀspring
and so are unable to discriminate against their non-inheritors.
A maternal gene that makes investment decisions behind this
meiotic ‘veil of ignorance’ has an equal likelihood of being
present in each of a mother’s oﬀspring [4]. Therefore, such
genes will be selected to maximize the mother’s total number
of surviving oﬀspring and to oppose the nepotistically epistatic
conspiracies of the minority of well-informed genes.
Inherited maternal haplotypes (IMHs) can also conspire
against the rest of the maternal genome, but here the con-
spiracy is one of favouritism rather than malice, of attempting
to give the current fetus a little extra advantage (relative to its
sibs) in the struggle for life [1]. Once again, the principal
barrier to the evolution of such systems is the absence of
reliable information about whether or not an oﬀspring has
inherited a particular allele.
In summary, most genes in mothers probably do not
discriminate among oﬀspring and are selected to maximize a
mother’s lifetime reproductive success. These genes will be
described as residing on non-discriminating maternal haplo-
types (NDMHs). However, a subset of genes (on discriminat-
ing NIMHs) may have been selected to cause the demise of
their non-inheritors, and a diﬀerent subset (on discriminating
IMHs) may have been selected to direct preferential care to
their inheritors.
Genes expressed in offspring
The question of whether an oﬀspring has inherited a copy of a
gene does not arise for genes expressed in oﬀspring. Therefore,
such genes will tend to favour maternal investment in their
particular oﬀspring (a sure bet) at the expense of maternal
investment in sibs (a risky bet). By contrast, there are no sure
bets for non-discriminating genes expressed in mothers: each
oﬀspring has one chance in two of inheriting a particular
maternal allele. This asymmetry of information is the basis of
the theory of parent–oﬀspring conﬂict [5]. As a result of the
additional information that genes in oﬀspring possess about
one toss of the meiotic coin, they will have been selected to
demand more resources from mothers than mothers will have
been selected to provide.
Questions of information do arise for genes expressed in
oﬀspring but, in this case, the question is not whether a gene
sits on an NIMH or an IMH but whether the gene sits on a
maternally derived fetal haplotype (MDFH) or a paternally
derived fetal haplotype (PDFH). Genes on an MDFH have
one chance in two of being present in each of a mother’s other
oﬀspring, whereas genes on a PDFH have less than one chance
in two because of the possibility of multiple paternity. There-
fore, if genes were informed about their parental origin, genes
on PDFHs would be selected to discount opportunity costs to
mothers more heavily than would genes on MDFHs [6,7].
Information about a gene’s parental origin is provided by
epigenetic modiﬁcations (genomic imprinting) established in
parental germ lines. Genes that are expressed in oﬀspring, but
that are uninformed about their parental origin, would be
selected to discount opportunity costs at a rate intermediate
between the rates favoured by MDFHs and PDFHs. Such
uninformed genes will be described as residing on non-
imprinted fetal haplotypes (NIFHs).
This section and the previous section have identiﬁed ﬁve
sets of genetic interests in the maternal-fetal unit (Table 1).
These are discriminating NIMHs, NDMHs, discriminating
IMHs (equivalent to imprinted MDFHs), NIFHs, and im-
printed PDFHs (arranged in order from lowest to highest
interest in the current fetus relative to other maternal oﬀ-
spring; [6].
BONES OF CONTENTION
As thou knowest not what is the way of the spirit, nor how the
bones do grow in the womb of her that is with child: even so thou
knowest not the works of God who makest all.
Ecclesiastes 11:5, King James Version
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gestational conﬂict will be of little use unless they can be used
to illuminate the organization of physiological processes during
pregnancy. Haig [3,4] has described various aspects of human
pregnancy when viewed under this light. One system I have
not previously considered is that of potential conﬂicts over the
allocation of calcium during pregnancy. This section will
present such a discussion as a prelude to a highly speculative
hypothesis to explain why the stimulatory G protein -subunit
(Gs) is translated only from transcripts of its maternally
derived allele in proximal renal tubules [8,9]. For the most
part, I will assume that the physiological processes I discuss
are determined by interactions between non-discriminating
maternal haplotypes (NDMHs) and non-imprinted fetal
haplotypes (NIFHs). I will not address possible eﬀects of
discriminating maternal haplotypes (either NIMHs or IMHs)
because I have been unable to think of plausible ways in which
well-informed maternal haplotypes could bias the supply of
maternal calcium. In the context of the eﬀects of fetal genes,
my default assumption is that genes are unimprinted unless
there is evidence to the contrary (as exists for GNAS, the gene
that encodes Gs). My focus will be on human pregnancy,
supplemented with evidence from laboratory rodents. Calcium
metabolism is complex and it is with some trepidation that I
take on a subject that is far from my own area of expertise. I
can only hope that the interest of a somewhat idiosyncratic
perspective can partially compensate for what will undoubtedly
b ean a ı ¨ve presentation.
Calcium exists in the body in two compartments: (i) a large
insoluble pool, stored in bone in ﬁxed stoichiometric ratio with
phosphate; (ii) a much smaller soluble pool in extracellular and
intracellular ﬂuids. The calcium concentration of the soluble
pool must be tightly regulated: short-term increases of soluble
calcium can be compensated by increased excretion of calcium
in urine; short-term deﬁciencies can be compensated by
releasing calcium (with phosphate) from bone and by increased
reabsorption of calcium in the kidney [10].
Two hormones, parathyroid hormone (PTH) and 1,25-
dihydroxyvitamin D (1,25(OH)2D), are principally responsible
for the short- to medium-term regulation of serum calcium.
PTH has a half-life in plasma of 2–4 min [11] and is released
when serum calcium falls below its set point. PTH causes the
withdrawal of calcium from bone and increases reabsorption of
calcium in the distal renal tubule. These eﬀects serve to restore
serum calcium to its set point. PTH also promotes the
formation of 1,25(OH)2D from 25-hydroxyvitamin D in the
proximal renal tubule. 1,25(OH)2D has a half-life in circulation
of about 6 h [12]. Thus, its concentration integrates the
degree to which calcium withdrawals have been made from
bone over the course of a few hours. 1,25(OH)2D increases
intestinal absorption of calcium and prepares bone for future
withdrawals [13].
The ﬁxed stoichiometry of calcium and phosphate in bone
means that their regulation is coupled. Phosphate is required
to deposit calcium in bone and is released when calcium is
mobilized from bone. Despite their ﬁxed ratio in bone, calcium
is dear but phosphate is cheap. That is, phosphate is more
readily available in the diet, relative to requirements, than is
calcium [14]. Therefore, the body can aﬀord to be more
proﬂigate with phosphate than with calcium: approximately 99
per cent of the ﬁltered load of calcium is reabsorbed by renal
tubules [15] whereas only 80–85 per cent of the ﬁltered load of
phosphate is reabsorbed [16]. One of PTH’s action is to
decrease the reabsorption of phosphate in the proximal renal
tubule [17]. By this means, PTH can increase serum calcium
without a concomitant rise in serum phosphate.
Calcium metabolism in pregnancy
The human neonatal skeleton contains about 30 g calcium,
most deposited during third trimester [18]. During pregnancy,
calcium is pumped across the placenta to establish a higher
concentration of ionized calcium in fetal serum than in
maternal serum. A particular maternal-fetal gradient is not
maintained. Rather, the fetus has a higher set point for serum
calcium that is maintained independently of the ambient
maternal concentration [19]. Pregnancy therefore entails a ﬂux
of calcium from the maternal soluble pool through the fetal
soluble pool into fetal bone, with the maternal soluble pool
being topped up from maternal dietary intake and release from
maternal bone. Except in exceptional circumstances, this ﬂux
is maintained independently of maternal dietary intake,
with any deﬁcit between fetal accretion and maternal intake
occurring at the expense of the mother’s skeleton.
Parathyroid hormone-related peptide (PTHrP) stimulates
calcium transport across the basal membrane of human syn-
cytiotrophoblast [20] and the maternal-fetal calcium gradient is
reduced in PTHrP knockout mice [21]. These results suggest
that fetal serum calcium levels are maintained by parathyroid
hormone-related peptide (PTHrP) regulating the placental
calcium pump. The release of PTHrP by human cytotropho-
blasts is regulated by extracellular calcium, but is inhibited by
a higher concentration of extracellular calcium than that which
inhibits PTH release from the parathyroid [22]. This diﬀer-
ence could account for the higher set point of fetal calcium. If
PTHrP activates the calcium pump at a higher calcium
Table 1. The probability that a particular haplotype is present in
the current oﬀspring (P1) or another oﬀspring (P2) of the same
mother (probabilities calculated for identity by immediate common
descent; p is the probability that other oﬀspring have the same
father as the current oﬀspring). P1/P2 is a measure of a haplotype’s
degree of ‘preference’ for maternal investment in the current
oﬀspring rather than other oﬀspring
Haplotype P1 P2 P1/P2
Non-inherited maternal 0 1/2 0
Non-discriminating maternal 1/2 1/2 1
Inherited maternal 1 1/2 2
Non-imprinted fetal 1 (1+p)/4 4/(1+p)
Paternally derived fetal 1 p/2 2/p
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calcium release from maternal bone, then short-term deﬁcits in
serum calcium will be compensated by calcium release from
the maternal skeleton, rather than from the fetal skeleton.
The principal maternal response to the increased calcium
demands of pregnancy is to increase the extraction of calcium
from diet. Intestinal uptake of calcium is increased during
pregnancy, probably in response to elevated levels of
1,25(OH)2D in maternal serum. The gestational increase in
intestinal uptake is usually in excess of fetal needs and is
accompanied by increased urinary excretion of calcium [23].
Despite this, there is evidence of increased maternal bone
turnover, in both pregnant women and rats [18], and evidence
for a decline in maternal bone mineral density during
pregnancy (women: [24,25]; rats: [26]).
There is some evidence that a fetus will withdraw calcium
from its own skeleton if the ﬂux across the placenta is
inadequate. Thus, fetuses of mothers with untreated hypo-
parathyroidism exhibit symptoms of hyperparathyroidism,
including bone resorption and reduced bone mineralization
[27,28]. In such pregnancies, the inability of a mother to
maintain normal levels of serum calcium, because of her
untreated PTH-deﬁciency, appears to result in activation of
fetal PTH and mobilization of calcium from fetal bone.
Similarly, knockouts of the calcium-sensing receptor cause
elevated PTH and increased bone resorption in fetal mice [19].
A maternal-fetal phosphate gradient is also maintained
across the placenta [10]. However, I conjecture that the
opportunity cost of phosphate transfers during pregnancy is
usually less than the opportunity cost of calcium transfers
because of the greater availability of phosphate in the diet
(relative to needs). If it were metabolically possible, mothers
would be prepared to spend phosphate to save calcium.
In summary, the fetus appears to withdraw calcium freely
from maternal serum, dictated solely by its own needs and
without regard to the needs of its mother. If maternal dietary
intake is adequate, the potential for conﬂict is largely limited to
costs associated with the insensitivity of fetal demands to
short-term ﬂuctuations in maternal calcium supply. However,
if maternal dietary intake is inadequate, the fetal skeleton will
develop largely at the expense of the maternal skeleton. Why
does one need to invoke evolutionary conﬂict to explain this
organization of calcium metabolism? A skeptic might argue
that the fetal needs are given ﬁrst priority because this
maximizes maternal ﬁtness. In the next section, I propose that
imprinting of GNAS in proximal renal tubules has evolved
because marginal reallocations of calcium from the fetus to the
mother have been associated with enhanced maternal ﬁtness.
Gs and the phosphate-depletion hypothesis
GNAS is perhaps the most complex of all imprinted loci, with
multiple gene products transcribed from multiple promoters
in a complex tissue-speciﬁc pattern. Some transcripts are
expressed only from the maternally derived allele, some only
from the paternally derived allele, and some show imprinted or
biallelic expression depending on cell type. Some transcripts
are translated, whereas others function solely as RNAs. One
transcript is antisense to an oppositely imprinted transcript.
Another encodes two interacting proteins in overlapping
reading frames [29–32]. In this section, I will attempt an
evolutionary explanation for a small part of this complexity.
Speciﬁcally, I will present a hypothesis to account for the
pattern of imprinting of transcripts encoding Gs in the renal
tubule.
Heterozygous inactivating mutations of Gs in humans
result in a suite of characters known as Albright’s hereditary
osteodystrophy (AHO). Of particular signiﬁcance, these
include mutations in an exon (exon 1) that is present only
in spliced transcripts encoding Gs [33]. Therefore, AHO
appears to be caused by haploinsuﬃciency for Gs in tissues
where transcripts are normally expressed from both parental
alleles. Individuals with a mutation of their maternally derived
allele display resistance to the eﬀects of PTH in the proximal
renal tubule in addition to AHO, a combination of symptoms
known as pseudohypoparathyroidism type Ia (PHP-Ia). By
contrast, individuals with a mutation of their paternally
derived allele exhibit AHO without hormone resistance, a
combination known as pseudopseudohypoparathyroidism
(PPHP) [34]. Both PHP-Ia and PPHP can be caused by
mutations in exon 1 [35]. Therefore, hormone resistance
appears to be caused by an absence of Gs function in cells in
which the protein is normally produced predominantly, or
exclusively, from transcripts of the maternally derived allele.
Resistance to PTH appears to be restricted to proximal tubules
because distal tubules [36] and the skeleton [37] maintain their
responsiveness to PTH. Evidence from mice that are hetero-
zygous for inactivating mutations suggest that Gs is translated
only from the maternally derived allele in proximal renal
tubules, but is translated from both alleles in the distal tubule
[8].
Individuals with PTH-resistance of the proximal tubule,
but without AHO, are described as having pseudohypo-
parathyroidism type Ib (PHP-Ib). Most patients with PHP-Ib
show biallelic expression of transcripts containing exon 1A (an
alternative ﬁrst exon) and a lack of methylation of both
copies of exon 1A. The maternally derived allele of exon 1A
is normally methylated and transcriptionally silent [9]
Transcripts containing exon 1A are probably untranslated [38].
One individual with PHP-Ib has been described with paternal
uniparental disomy for GNAS [39]. Three brothers have been
reported with selective resistance to PTH, but without AHO,
caused by a mutation in exon 13 that prevents Gs interacting
with the PTH receptor. These siblings inherited the mutation
from their unaﬀected mother, who inherited it from her
unaﬀected father [40]. A hypothesis that unites these diverse
clinical data is that transcription of exon 1A in proximal renal
tubules somehow results in a failure to produce functional Gs
in cis.
Gs is released when PTH binds to PTH receptors at the
surface of epithelial cells of renal tubules. After its release, Gs
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cyclase. Elevated cAMP appears to mediate two of the princi-
pal eﬀects of PTH in the proximal tubule. The ﬁrst is the
retrieval of NPT2a (the principal sodium/inorganic phosphate
cotransporter) from apical brush border membranes, thus
reducing phosphate reabsorption [17]. The second is the
stimulation of 1-hydroxylation of vitamin D to produce the
active metabolite 1,25(OH)2D [10]. In the distal tubule, PTH
promotes increased reabsorption of calcium [15].
The kinship theory of genomic imprinting predicts that
paternally derived alleles are inactivated when matrilineal
inclusive ﬁtness is maximized by a higher level of gene product
than that which maximizes patrilineal inclusive ﬁtness [41].
Thus, the phenotypic silence of the paternal allele encod-
ing Gs in proximal renal tubules suggests that patrilineal
inclusive ﬁtness would be increased, and matrilineal inclusive
ﬁtness decreased, by reduced retrieval of NPT2a and hence
increased reabsorption of phosphate. Conversely, matrilineal
inclusive ﬁtness would be enhanced by increased excretion of
phosphate. It seems reasonable ﬁrst to consider possible
selective forces that act during gestation, and involve the
opportunity costs that care for a fetus imposes on its mother,
before considering more complicated models that invoke post-
natal interactions among kin. (PTH also causes increased
production of 1,25(OH)2D in proximal renal tubules. How-
ever, conﬂict over the level of production of 1,25(OH)2D is not
a promising candidate to explain imprinted expression of Gs
because mice with targeted ablation of 25-dihydroxyvitamin D
1-hydroxylase appear grossly normal before weaning [42].)
I propose that Gs acts to reduce retention of phosphate by
the proximal tubule because of the indirect eﬀect this has on
the calcium ﬂux across the placenta. This mechanism is
proposed to be activated when mothers are calcium-stressed.
To a ﬁrst-order approximation, the calcium ﬂux in third
trimester should equal the rate of accretion of calcium in fetal
bone. Therefore, if bone mineralization could be slowed by a
relative scarcity of phosphate, then the placental pump for
calcium would be down-regulated to prevent fetal hyper-
calcemia. In this scenario, the paternally derived allele of
GNAS is silent in proximal tubules because patrilineal inter-
ests are promoted by maintaining a higher rate of fetal bone
mineralization. By contrast, the maternally derived allele is
expressed because marginal increases in the excretion of
phosphate reduce the rate at which calcium can be deposited in
fetal bone and thus, indirectly, reduce the rate at which
calcium is lost from the maternal skeleton. Under conditions of
maternal calcium stress, paternally-derived alleles of the fetus
favour retention of both calcium and phosphate to maintain the
calcium ﬂux into fetal bone, whereas maternally-derived alleles
favour depletion of phosphate (but retention of calcium) to
reduce the calcium ﬂux across the placenta. This provides an
adaptive explanation of why the paternal copy of Gs is silent
in the proximal tubule but remains active in the distal tubule
where its eﬀect is to promote uptake of calcium. Phosphate
(and calcium) voided in fetal urine can be recovered from
amniotic ﬂuid, but the hypothesis predicts that the marginal
eﬀect of increased excretion of phosphate is reduced bone
deposition and down-regulation of the placental calcium
pump.
The hypothesis predicts that a marginal decrease in
expression of Gs in proximal tubules would result in
increased fetal bone mineralization under conditions of calcium
stress, accompanied by increased loss of calcium from the
maternal skeleton. Testing this prediction would be challeng-
ing. A test would be somewhat less daunting if the predicted
eﬀects of a marginal decrease in expression under calcium
stress can be extrapolated to the eﬀects of complete absence of
expression of Gs under normal availability of calcium. If so,
the hypothesis predicts greater mineralization of the neonatal
skeleton in PHP-Ia (and PHP-Ib) than in PPHP. Knockouts of
Gs in mice (e.g., [8]) would allow these predictions to be
tested in calcium-stressed mothers.
The phosphate-depletion hypothesis is a ﬁrst attempt to
explain the imprinting of GNAS in proximal renal tubules.
Among its weaknesses, the hypothesis assumes that the (largely
unstudied) functions of PTH and Gs in the fetal kidney
resemble their functions in the postnatal kidney. These
assumptions are, of course, testable. Zheng et al. [43] found no
evidence of monoallelic expression of exon 1 transcripts in
samples of kidney cortex from a human fetus with PHP-Ib.
This suggests that expression of Gs may not be imprinted in
fetal kidney, although it is possible that evidence of imprinting
may have been obscured by the samples containing a mixture
of cells with monoallelic and biallelic expression [44]. More-
over, Zheng et al. [43] did not provide evidence on the
expression of exon 1A transcripts, nor whether exon 1 tran-
scripts of both alleles were translated. The phosphate-
depletion hypothesis proposes that the selective force
favouring imprinting is the calcium demand on mothers during
pregnancy, even though there is an even greater calcium
demand during lactation [45]. However, the ability of genes
expressed in oﬀspring to inﬂuence the maternal supply of
calcium appear much more limited during lactation than
during gestation.
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